Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
6
self-reported band not used
Office countries
1
1 address
Company type
Educational
self-reported
Description
The Australian Translational Medicinal Chemistry Facility (ATMCF) is a purpose-designed and outward-facing collaborative facility, translating new discoveries in disease biology into suitably targeted therapeutics for clinical development.
ATMCF partners with suitable researchers and companies to efficiently and effectively address the multifaceted requirements of drug-discovery.
We optimise small bioactive molecules into high performance drug candidates by making them more drug-like, potent, selective and efficacious, and in a clear space for licensing.
We work strategically with partners in a cost-effective manner to navigate through the pitfalls of drug discovery, by working through key-decision gates, e.g. suitability of molecules as starting points for optimisation, intellectual properties, target-validation, and proof-of-concept studies. Subject to the proof-of-concept, we undertake a medicinal chemistry-directed optimisation to ensure that the target product profile for the drug candidate is met.
Based on the specified agreements, we can collaborate from the starting molecules through to a well characterised and optimised drug candidate, and assist with further pre-clinical development for clinical trials, or we can pass the optimised compounds (or lead-series) and the associated IP back to the partner.
We can undertake more targeted efforts in the synthesis, such as by carefully designing pharmacological probes, generating specific active compounds including natural products, and introducing bio-conjugation of small-molecules into targeting peptides.
The ATMCF has seamless and facilitated access to a number of ancillary partners to excel in medicinal chemistry and ADME-lead optimisation.
Specialties
All 8 specialties
- Medicinal Chemistry
- APHID
- Small molecules
- High-throughput screening (HTS) hit selections
- Drug discovery program planning
- Structure-activity relationship (SAR) study designs
- Mechanism and structure-based drug designs
- Translation of biomedical research to clinical relevance
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU399 Royal Parade; Parkville, Victoria 3052Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at ATMCF?
The record holds 6 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does ATMCF have offices?
One address on record, Australia only. Primary: 399 Royal Parade, Parkville, Victoria 3052.
Has ATMCF raised funding?
None linked to this brand.
What does ATMCF list as its specialties?
Eight tags on the brand's own list, among them Medicinal Chemistry, APHID and Small molecules.
Which companies are listed alongside ATMCF?
2 profiles list ATMCF as a peer — 56th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. MedChem Australia lists it back.